Literature DB >> 35400920

Exploring an Unfathomed Entiry: A Pooled Analysis of Solitory Skeletal Muscle Metastasis from Head and Neck Squamous Cell Carcinoma.

Dharma Ram Poonia1,2, Suhas Kodasoge Rajappa2, Ajay K Dewan2, Amit Sehrawat3, Chaturbhuj Agrawal4, Koyyala Venkata Pradeep Babu4.   

Abstract

Background: Skeletal muscle is relatively uncommon site for metastasis in head and neck primary. This study was conducted to report our experience of three such cases and analyze the previously reported cases to assess the overall outcomes and formulate a treatment plan for these patients.
Methods: We pooled the data extracted on extensive literature review and analyzed.
Results: A total of 17 patients were analyzed for this study. All the patients had locally advanced primary and 14/17 developed metachronous metastasis. Median duration to development of metastasis was 8.5 months, and 13/17 patients had skeletal muscle as the only site of metastasis. Only 6/13 were treated with aggressive intent, 4 of which who underwent surgical resection had the best survival outcomes. Conclusions: Isolated skeletal muscle metastasis in a head and neck primary is relatively rare, and in future, the research work needs to be taken up afresh, on prospective model, with adequate patient sample, to draw a scientifically valid conclusion. © The Association of Oral and Maxillofacial Surgeons of India 2020.

Entities:  

Keywords:  Head and neck cancer; Metastatectomy; Oligo metastasis; Skeletal muscle metastasis; Squamous cell carcinoma

Year:  2020        PMID: 35400920      PMCID: PMC8934890          DOI: 10.1007/s12663-020-01353-8

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  34 in total

Review 1.  The mechanisms of spread of cancer.

Authors:  W H Cole
Journal:  Surg Gynecol Obstet       Date:  1973-11

Review 2.  Skeletal muscle metastases: a three-part study of a not-so-rare entity.

Authors:  Tamara Miner Haygood; Jason Wong; Jennifer Cha Lin; Sylvia Li; Aurelio Matamoros; Colleen M Costelloe; Henry Yeung; Carl M Sandler; Rodolfo F Nunez; Rajendra Kumar; John E Madewell
Journal:  Skeletal Radiol       Date:  2011-11-20       Impact factor: 2.199

Review 3.  Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Authors:  Assuntina G Sacco; Ezra E Cohen
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

Review 4.  Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature.

Authors:  T A Damron; J Heiner
Journal:  Ann Surg Oncol       Date:  2000-08       Impact factor: 5.344

5.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

6.  Intramuscular metastasis of carcinoma.

Authors:  A Sudo; Y Ogihara; Y Shiokawa; S Fujinami; S Sekiguchi
Journal:  Clin Orthop Relat Res       Date:  1993-11       Impact factor: 4.176

7.  Possible reasons for the high resistance of muscle to cancer.

Authors:  S Seely
Journal:  Med Hypotheses       Date:  1980-02       Impact factor: 1.538

8.  Skeletal muscle metastases from lung cancer.

Authors:  K S Sridhar; R K Rao; B Kunhardt
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

9.  Metastasis of laryngeal squamous cell carcinoma to bilateral thigh muscles.

Authors:  Zarah Lucas; Akash Mukherjee; Stanley Chia; Irina Veytsman
Journal:  Case Rep Oncol Med       Date:  2014-12-14

10.  Multiple skeletal muscle metastases from poorly differentiated gastric adenocarcinoma.

Authors:  Yuki Koga; Yoshifumi Baba; Kazuto Harada; Keisuke Kosumi; Hironobu Shigaki; Junji Kurashige; Takatsugu Ishimoto; Masaaki Iwatsuki; Yuji Miyamoto; Yasuo Sakamoto; Naoya Yoshida; Hideo Baba
Journal:  Surg Case Rep       Date:  2015-10-15
View more
  1 in total

1.  The road less travelled: Skeletal muscle invasion in oral squamous cell carcinoma.

Authors:  Shreya Chatterjee; Anju Devi; Mala Kamboj; Anjali Narwal; Rahul Anand; Ridhi Bhola
Journal:  J Oral Biol Craniofac Res       Date:  2022-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.